IFOSFAMIDE Side Effects

7023669-4 | Anaemia, Body Temperature Decreased, Catheter Site Erythema, Catheter Site Swelling, Device Related Infection, Staphylococcal Infection
on Sep 29, 2010 Female patient from UNITED STATES , weighting 154.3 lb, was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, body temperature decreased, catheter site erythema, catheter site swelling, device related infection, staphylococcal infection (What is staphylococcal infection?). Ifosfamide dosage: 8.58 Mg. During the same period patient was treated with TAXOL (243 Mg) (View Taxol Review and Taxol Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

7014307-5 | Blood Pressure Increased, Depressed Level Of Consciousness, Heart Rate Increased, Hypoxia, Metabolic Encephalopathy, Mydriasis, Nausea, Respiratory Distress, Retching
Patient was taking Ifosfamide (View Usage). Patient had the following side effects: blood pressure increased, depressed level of consciousness, heart rate increased, hypoxia, metabolic encephalopathy, mydriasis, nausea (What is nausea?), respiratory distress, retching on Sep 24, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 174.0 lb, was diagnosed with neoplasm malignant and. Ifosfamide dosage: 4650 Mg Qday Iv. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), MESNA (View Mesna Review and Mesna Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ). Patient was hospitalized.

7005288-9 | Febrile Neutropenia, White Blood Cell Count Decreased
Adverse event was reported on Sep 20, 2010 by a Male patient taking Ifosfamide (View Usage) (Dosage: 2.5 G/m2, 21 Day Int, Iv) was diagnosed with sarcoma and. Location: UNITED STATES , 62 years of age, weighting 218.0 lb, After Ifosfamide was administered, patient had the following side effects: febrile neutropenia, white blood cell count decreased. During the same period patient was treated with DOXORUBICIN HCL (75 Mg/m2, 21 Day Int, Iv) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

6983417-0 | Dyspnoea, Lung Disorder, Neutropenia, Pseudomonas Test Positive, Pyrexia
on Sep 14, 2010 Female patient from UNITED STATES , weighting 192.7 lb, was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, lung disorder, neutropenia, pseudomonas test positive, pyrexia. Ifosfamide dosage: 8910 Mg. During the same period patient was treated with TAXOL (250 Mg) (View Taxol Review and Taxol Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.


6969418-7 | Agitation, Anxiety, Confusional State, Dysarthria, Dystonia, Extrapyramidal Disorder, Hallucination, Hypokinesia, Lethargy
on Aug 17, 2010 Male patient from SPAIN , 38 years of age, was diagnosed with hodgkin's disease mixed cellularity stage iv and was treated with Ifosfamide (View Usage). Patient had the following side effects: agitation, anxiety (What is anxiety?), confusional state, dysarthria, dystonia (What is dystonia?), extrapyramidal disorder, hallucination, hypokinesia, lethargy. Ifosfamide dosage: 92000 Mg/m2, Days 1-4). During the same period patient was treated with MESNA (MESNA) (MESNA) (View Mesna (mesna) (mesna) Review and Mesna (mesna) (mesna) Label ), GENCITABINE (GEMCITABINE) (GEMCITABINE) (View Gencitabine (gemcitabine) (gemcitabine) Review and Gencitabine (gemcitabine) (gemcitabine) Label ), VINORELBINE (VINORELBINE) (VINORELBINE) (View Vinorelbine (vinorelbine) (vinorelbine) Review and Vinorelbine (vinorelbine) (vinorelbine) Label ).

6937758-3 | Toxic Encephalopathy
Patient was taking Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: toxic encephalopathy on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 146.4 lb, was diagnosed with burkitt's lymphoma and. Ifosfamide dosage: 3320mg (200mg/m2) Daily Over 2 Hours Intravenous. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), VINORELBINE (View Vinorelbine Review and Vinorelbine Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MESNA (View Mesna Review and Mesna Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6936903-3 | Faecal Incontinence, Muscular Weakness, Oedema Peripheral, Polyneuropathy, Urinary Incontinence
Adverse event was reported on Aug 18, 2010 by a Female patient taking Ifosfamide (View Usage) (Dosage: ) was diagnosed with central nervous system lymphoma and. Location: UNITED STATES , 59 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: faecal incontinence, muscular weakness, oedema peripheral, polyneuropathy, urinary incontinence (What is urinary incontinence?). During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ARA C (View Ara-c Review and Ara-c Label ), THIOTEPA (1df- 40unk) (View Thiotepa Review and Thiotepa Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ).

6882092-3 | Febrile Neutropenia, Impaired Healing, Pseudomonas Infection, Skin Graft
on Jul 28, 2010 Male patient from UNITED STATES , weighting 275.6 lb, was treated with Ifosfamide (View Usage). Patient had the following side effects: febrile neutropenia, impaired healing, pseudomonas infection, skin graft. Ifosfamide dosage: 18000 Mg. During the same period patient was treated with MESNA (14400 Mg) (View Mesna Review and Mesna Label ). Patient was hospitalized.

6815202-4 | Hypertension, No Therapeutic Response
on Jun 30, 2010 Female patient from UNITED STATES , weighting 183.3 lb, was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: hypertension, no therapeutic response. Ifosfamide dosage: 8.4 G. During the same period patient was treated with TAXOL (238 Mg) (View Taxol Review and Taxol Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6770629-4 | Klebsiella Infection
Patient was taking Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: klebsiella infection on Jun 08, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 220.5 lb, was diagnosed with lymphoma (What is lymphoma?), systemic candida, neutropenia and. Ifosfamide dosage: . During the same period patient was treated with UROMITEXAN BAXTER (View Uromitexan Baxter Review and Uromitexan Baxter Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), LENOGRASTIM (View Lenograstim Review and Lenograstim Label ). Patient was hospitalized.

6759185-4 | Hypertensive Crisis, Pulmonary Oedema
Adverse event was reported on May 27, 2010 by a Male patient taking Ifosfamide (View Usage) (Dosage: ) was diagnosed with testis cancer and. Location: GERMANY , 45 years of age, Patient had the following side effects: hypertensive crisis, pulmonary oedema. During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6740795-5 | Pulmonary Embolism
on May 25, 2010 Female patient from UNITED STATES , weighting 183.3 lb, was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Ifosfamide dosage: 2.8 G. During the same period patient was treated with TAXOL (239 Mg) (View Taxol Review and Taxol Label ).

6732738-5 | Attention Deficit/hyperactivity Disorder, Growth Hormone Deficiency, Mental Impairment
on May 11, 2010 Male patient from JAPAN , child 11 years of age, was diagnosed with pineal germinoma and was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: attention deficit/hyperactivity disorder, growth hormone deficiency, mental impairment. Ifosfamide dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6732609-4 | Hypokalaemia
Patient was taking Ifosfamide (View Usage). Patient had the following side effects: hypokalaemia on May 12, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 52 years of age, weighting 70.55 lb, was diagnosed with neoplasm malignant and. Ifosfamide dosage: .

6731416-6 | Asthenia, Confusional State, Disorientation, Mental Status Changes
Adverse event was reported on May 18, 2010 by a Female patient taking Ifosfamide (View Usage) (Dosage: 5568 Mg) . Location: UNITED STATES , weighting 152.1 lb, After Ifosfamide was administered, patient had the following side effects: asthenia, confusional state, disorientation, mental status changes. During the same period patient was treated with TAXOL (234 Mg) (View Taxol Review and Taxol Label ), NEULASTA (6 Mg) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6723790-1 | Hypokalaemia
on May 05, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 52 years of age, weighting 70.55 lb, was diagnosed with neoplasm malignant and was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia. Ifosfamide dosage: .

6721726-0 | Ballismus, Encephalopathy, Movement Disorder, Urinary Incontinence
on May 01, 2010 Female patient from UNITED STATES , child 7 years of age, was diagnosed with bone sarcoma and was treated with Ifosfamide (View Usage). Patient had the following side effects: ballismus, encephalopathy, movement disorder (What is movement disorder?), urinary incontinence (What is urinary incontinence?). Ifosfamide dosage: Dose Unit:grams Per Meters Squared. During the same period patient was treated with MESNA (View Mesna Review and Mesna Label ), ONDASETRON (View Ondasetron Review and Ondasetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DRONABINOL (View Dronabinol Review and Dronabinol Label ).

6721724-7 | Encephalopathy, Movement Disorder
Patient was taking Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: encephalopathy, movement disorder (What is movement disorder?) on May 01, 2010 from UNITED STATES Additional patient health information: Male patient , 16 years of age, was diagnosed with bone sarcoma and. Ifosfamide dosage: Dose Unit:grams Per Meters Squared. During the same period patient was treated with MESNA (View Mesna Review and Mesna Label ), DOLASETRON (View Dolasetron Review and Dolasetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ).

6714094-1 | Attention Deficit/hyperactivity Disorder, Growth Hormone Deficiency, Mental Impairment
Adverse event was reported on Apr 27, 2010 by a Male patient taking Ifosfamide (View Usage) (Dosage: ) was diagnosed with pineal germinoma and. Location: JAPAN , child 11 years of age, Patient experienced the following unwanted or unexpected effects: attention deficit/hyperactivity disorder, growth hormone deficiency, mental impairment. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6709785-2 | Bone Marrow Failure, Cellulitis, Renal Failure Chronic
on Apr 26, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with liposarcoma metastatic, prophylaxis, prophylaxis against dehydration, prophylaxis of nausea and vomiting and was treated with Ifosfamide (View Usage). Patient had the following side effects: bone marrow failure, cellulitis (What is cellulitis?), renal failure chronic. Ifosfamide dosage: Dose Unit:grams Per Meters Squared. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), MESNA (View Mesna Review and Mesna Label ), DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (View Dextrose 5% And Sodium Chloride 0.45% In Plastic Container Review and Dextrose 5% And Sodium Chloride 0.45% In Plastic Container Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), GRANULOCYTE COLONY STIMULATING FACTOR (View Granulocyte Colony Stimulating Factor Review and Granulocyte Colony Stimulating Factor Label ).

6709778-5 | Disease Progression, Epistaxis, Renal Failure Chronic, Thrombocytopenia
on Apr 26, 2010 Male patient from UNITED STATES , 48 years of age, was diagnosed with synovial sarcoma recurrent, prophylaxis, prophylaxis against dehydration and was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: disease progression, epistaxis, renal failure chronic, thrombocytopenia. Ifosfamide dosage: Dose Unit:grams Per Meters Squared. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), MESNA (View Mesna Review and Mesna Label ), DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (View Dextrose 5% And Sodium Chloride 0.45% In Plastic Container Review and Dextrose 5% And Sodium Chloride 0.45% In Plastic Container Label ).

6690734-0 | Epilepsy, Hypokalaemia
Patient was taking Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?), hypokalaemia on Apr 13, 2010 from JAPAN Additional patient health information: Female patient , 37 years of age, was diagnosed with cervix carcinoma and. Ifosfamide dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6686225-3 | Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Apr 15, 2010 by a Female patient taking Ifosfamide (View Usage) (Dosage: 4130mg Once Iv) was diagnosed with neuroendocrine carcinoma and. Location: UNITED STATES , 61 years of age, weighting 140.0 lb, Patient had the following side effects: inappropriate antidiuretic hormone secretion. Patient was hospitalized.

6678596-9 | Hypokalaemia, Hypomagnesaemia, Hypophosphataemia, Metabolic Acidosis, Nausea
on Apr 12, 2010 Female patient from UNITED STATES , 58 years of age, weighting 171.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: hypokalaemia, hypomagnesaemia, hypophosphataemia, metabolic acidosis, nausea (What is nausea?). Ifosfamide dosage: Iv. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6641578-7 | Confusional State, Mental Status Changes, Movement Disorder, Speech Disorder
on Mar 17, 2010 Female patient from UNITED STATES , 49 years of age, weighting 110.0 lb, was diagnosed with central nervous system lymphoma, neoplasm malignant and was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, mental status changes, movement disorder (What is movement disorder?), speech disorder. Ifosfamide dosage: 965mg Q12 X 10days Iv. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), COTRIM (View Cotrim Review and Cotrim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6641291-6 | Abdominal Pain, Accidental Overdose, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Candida Sepsis, Convulsion, Flatulence, Ileus
Patient was taking Ifosfamide (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), accidental overdose, acute respiratory distress syndrome, bone marrow failure, candida sepsis, convulsion, flatulence, ileus on Mar 09, 2010 from FRANCE Additional patient health information: Male patient , child 6 years of age, weighting 52.91 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Ifosfamide dosage: . During the same period patient was treated with UROMITEXAN BAXTER (View Uromitexan Baxter Review and Uromitexan Baxter Label ), NAVELBINE (View Navelbine Review and Navelbine Label ), MITOGUAZONE (View Mitoguazone Review and Mitoguazone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), NALBUPHINE (View Nalbuphine Review and Nalbuphine Label ). Patient was hospitalized.

6609669-4 | Accidental Overdose, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Candida Sepsis, Convulsion, Flatulence, Ileus, Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Feb 19, 2010 by a Male patient taking Ifosfamide (View Usage) (Dosage: ) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: FRANCE , child 6 years of age, weighting 52.91 lb, After Ifosfamide was administered, patient had the following side effects: accidental overdose, acute respiratory distress syndrome, bone marrow failure, candida sepsis, convulsion, flatulence, ileus, inappropriate antidiuretic hormone secretion. During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), MITOGUAZONE (View Mitoguazone Review and Mitoguazone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6587995-5 | Accidental Overdose, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Convulsion, Flatulence, Ileus, Inappropriate Antidiuretic Hormone Secretion, Mucosal Inflammation
on Feb 09, 2010 Male patient from FRANCE , child 6 years of age, weighting 52.91 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, acute respiratory distress syndrome, bone marrow failure, convulsion, flatulence, ileus, inappropriate antidiuretic hormone secretion, mucosal inflammation. Ifosfamide dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), MITOGUAZONE (View Mitoguazone Review and Mitoguazone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6583569-0 | Anaemia, Cholecystitis Acute, Febrile Neutropenia, Hepatotoxicity, Infection, Thrombocytopenia, Urosepsis
on Feb 05, 2010 Female patient from GERMANY , 62 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Ifosfamide (View Usage). Patient had the following side effects: anaemia, cholecystitis acute, febrile neutropenia, hepatotoxicity, infection (What is infection?), thrombocytopenia, urosepsis. Ifosfamide dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized and became disabled.

6578618-X | Accidental Overdose, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Convulsion, Flatulence, Ileus, Inappropriate Antidiuretic Hormone Secretion, Mucosal Inflammation
Patient was taking Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: accidental overdose, acute respiratory distress syndrome, bone marrow failure, convulsion, flatulence, ileus, inappropriate antidiuretic hormone secretion, mucosal inflammation on Feb 02, 2010 from FRANCE Additional patient health information: Male patient , child 6 years of age, weighting 52.91 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Ifosfamide dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), MITOGUAZONE (View Mitoguazone Review and Mitoguazone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6570768-7 | Accidental Overdose, Bone Marrow Failure, Convulsion, Flatulence, Ileus, Inappropriate Antidiuretic Hormone Secretion, Mucosal Inflammation, Nervous System Disorder
Adverse event was reported on Jan 25, 2010 by a Male patient taking Ifosfamide (View Usage) (Dosage: ) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: FRANCE , child 6 years of age, weighting 52.91 lb, Patient experienced the following unwanted or unexpected effects: accidental overdose, bone marrow failure, convulsion, flatulence, ileus, inappropriate antidiuretic hormone secretion, mucosal inflammation, nervous system disorder. During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), MITOGUAZONE (View Mitoguazone Review and Mitoguazone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6569628-7 | Confusional State, Lethargy, Mental Status Changes, Somnolence
on Feb 03, 2010 Female patient from UNITED STATES , weighting 199.7 lb, was diagnosed with sarcoma and was treated with Ifosfamide (View Usage). Patient had the following side effects: confusional state, lethargy, mental status changes, somnolence. Ifosfamide dosage: 5490 Mg Q24 Hr X 5 Days Continuous Infusion. Patient was hospitalized.

6565983-2 | Fanconi Syndrome, Renal Failure Acute, Staphylococcal Osteomyelitis
on Jan 29, 2010 Male patient from UNITED STATES , 63 years of age, weighting 163.1 lb, was diagnosed with neoplasm malignant and was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: fanconi syndrome, renal failure acute, staphylococcal osteomyelitis. Ifosfamide dosage: 10000 Mg Once Iv. During the same period patient was treated with CARBOPLATIN (400 Mg Iv) (View Carboplatin Review and Carboplatin Label ), MESNA (View Mesna Review and Mesna Label ).

6558284-X | Accidental Overdose, Bone Marrow Failure, Convulsion, Flatulence, Ileus, Inappropriate Antidiuretic Hormone Secretion
Patient was taking Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, bone marrow failure, convulsion, flatulence, ileus, inappropriate antidiuretic hormone secretion on Jan 20, 2010 from FRANCE Additional patient health information: Male patient , child 6 years of age, weighting 52.91 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Ifosfamide dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), MITOGUAZONE (View Mitoguazone Review and Mitoguazone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6508600-X | Encephalopathy
Adverse event was reported on Dec 11, 2009 by a Female patient taking Ifosfamide (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED KINGDOM , 49 years of age, Patient had the following side effects: encephalopathy.

6487683-X | Clostridium Difficile Colitis
on Dec 03, 2009 Female patient from GERMANY , 55 years of age, weighting 165.3 lb, was diagnosed with gastric sarcoma, pneumonia (What is pneumonia?), prophylaxis against gastrointestinal ulcer, hypertension, anxiety disorder, prophylaxis of nausea and vomiting and was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: clostridium difficile colitis. Ifosfamide dosage: . During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), METOPROLOL (95mg/0/47.5 Mg) (View Metoprolol Review and Metoprolol Label ), CIPRALEX (View Cipralex Review and Cipralex Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), MESNA (View Mesna Review and Mesna Label ). Patient was hospitalized.

6450706-8 | Confusional State, Disorientation, Mental Status Changes, Neurotoxicity
on Nov 20, 2009 Male patient from UNITED STATES , child 11 years of age, was diagnosed with ewing's sarcoma and was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, disorientation, mental status changes, neurotoxicity. Ifosfamide dosage: 4470 Mg -3g/m2-every 24 Hours @125ml/hr Over 4hr Iv. Patient was hospitalized.

6445263-6 | Agitation, Coma, Myoclonus
Patient was taking Ifosfamide (View Usage). Patient had the following side effects: agitation, coma, myoclonus on Apr 30, 2009 from SPAIN Additional patient health information: Female patient , 65 years of age, weighting 116.8 lb, was diagnosed with leiomyosarcoma, pain (What is pain?), neuralgia, prophylaxis and. Ifosfamide dosage: . During the same period patient was treated with DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CLEXANE (View Clexane Review and Clexane Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6425212-7 | Agitation, Communication Disorder, Myoclonus, Personality Change
Adverse event was reported on Oct 30, 2009 by a Female patient taking Ifosfamide (View Usage) (Dosage: 2300 Q24h X 5 Doses Iv) was diagnosed with ewing's sarcoma, primitive neuroectodermal tumour and. Location: UNITED STATES , weighting 90.39 lb, After Ifosfamide was administered, patient had the following side effects: agitation, communication disorder, myoclonus, personality change. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACETAMINOPHEN W/ CODEINE TAB (View Acetaminophen W/ Codeine Tab Review and Acetaminophen W/ Codeine Tab Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), HEPARIN LOCK FLUSH (View Heparin Lock-flush Review and Heparin Lock-flush Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MESNA (View Mesna Review and Mesna Label ).

6424847-5 | Blood Culture Positive, Escherichia Infection, Febrile Neutropenia
on Oct 26, 2009 Male patient from UNITED KINGDOM , 17 years of age, weighting 158.7 lb, was diagnosed with bone sarcoma and was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: blood culture positive, escherichia infection, febrile neutropenia. Ifosfamide dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIDOSE (View Calcidose Review and Calcidose Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), MOPRAL (View Mopral Review and Mopral Label ), LOVENOX (View Lovenox Review and Lovenox Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

6379741-5 | Hyponatraemia
on Sep 18, 2009 Male patient from UNITED STATES , 35 years of age, was diagnosed with metastases to meninges and was treated with Ifosfamide (View Usage). Patient had the following side effects: hyponatraemia. Ifosfamide dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

6377330-X | Depressed Level Of Consciousness, Mental Status Changes
Patient was taking Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: depressed level of consciousness, mental status changes on Sep 23, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 115.7 lb, was diagnosed with diffuse large b-cell lymphoma and. Ifosfamide dosage: 3 825mg Iv Q 12h. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ), DEXAMETHASONE 4MG TAB (View Dexamethasone 4mg Tab Review and Dexamethasone 4mg Tab Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6334901-4 | Acute Lymphocytic Leukaemia
Adverse event was reported on Aug 26, 2009 by a Female patient taking Ifosfamide (View Usage) (Dosage: 3 G/m2 X 3 Per Cycle Cumulative Dose 72 G/m2) was diagnosed with uterine cancer (What is uterine cancer?), metastases to lymph nodes and. Location: KOREA, REPUBLIC OF , child 11 years of age, Patient experienced the following unwanted or unexpected effects: acute lymphocytic leukaemia. During the same period patient was treated with DOXORUBICIN HCL (25 Mg/m2 X 3 Per Cycle Cumulative Dose 400mg/m2) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (1.5 Mg/m2 X 3 Per Cycle Cumulative Dose 34 Mg/m2) (View Vincristine Review and Vincristine Label ).

6316004-8 | Acute Lymphocytic Leukaemia
on Aug 17, 2009 Female patient from KOREA, REPUBLIC OF , child 11 years of age, was diagnosed with uterine cancer (What is uterine cancer?), metastases to lymph nodes and was treated with Ifosfamide (View Usage). Patient had the following side effects: acute lymphocytic leukaemia. Ifosfamide dosage: 3 Doses 1 Dosageform = 3g/m2 Cumulative Dose 72 G/m2. During the same period patient was treated with DOXORUBICIN HCL (2 Doses Cumulative Dose 400mg/m2) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

6312296-X | Convulsion, Depression, Dyspnoea, Malaise, Sepsis, Vomiting
on Aug 11, 2009 Female patient from JAPAN , 63 years of age, was diagnosed with lung cancer metastatic and was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: convulsion, depression (What is depression?), dyspnoea, malaise, sepsis (What is sepsis?), vomiting. Ifosfamide dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6305864-2 | Abnormal Behaviour, Depressed Level Of Consciousness, Gait Disturbance, Neurotoxicity
Patient was taking Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, depressed level of consciousness, gait disturbance, neurotoxicity on Apr 20, 2009 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, weighting 74.96 lb, was diagnosed with acute lymphocytic leukaemia and. Ifosfamide dosage: 3gm/60m1 Every Twenty Hours (2180 Mg),parenteral. During the same period patient was treated with MESNA (View Mesna Review and Mesna Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6305861-7 | Dyskinesia, Nervousness, Neurotoxicity, Somnolence, Tremor
Adverse event was reported on Apr 20, 2009 by a Male patient taking Ifosfamide (View Usage) (Dosage: 3gm/60ml Every 20 Hours (3260 Mg),parenteral) was diagnosed with bone sarcoma and. Location: UNITED STATES , 16 years of age, weighting 136.0 lb, Patient had the following side effects: dyskinesia, nervousness, neurotoxicity, somnolence, tremor. During the same period patient was treated with ACTIVASE (View Activase Review and Activase Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GRANISETROP (View Granisetrop Review and Granisetrop Label ). Patient was hospitalized.

6305835-6 | Coordination Abnormal, Distractibility, Gait Disturbance, Irritability, Neurotoxicity
on Apr 20, 2009 Male patient from UNITED STATES , child 2 years of age, weighting 29.54 lb, was diagnosed with rhabdoid tumour of the kidney and was treated with Ifosfamide (View Usage). After Ifosfamide was administered, patient had the following side effects: coordination abnormal, distractibility, gait disturbance, irritability, neurotoxicity. Ifosfamide dosage: 3gm/60ml Every Twenty Hours (1025 Mg) , Parenteral. During the same period patient was treated with MESNA (View Mesna Review and Mesna Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6299592-X | Delirium, Mental Status Changes
on Aug 05, 2009 Male patient from UNITED STATES , 58 years of age, was treated with Ifosfamide (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, mental status changes. Ifosfamide dosage: 1000 Iv Drip. Patient was hospitalized.

6294788-5 | Affect Lability, Disorientation, Fall, Telangiectasia, Tremor
Patient was taking Ifosfamide (View Usage). Patient had the following side effects: affect lability, disorientation, fall (What is fall?), telangiectasia, tremor on Jul 31, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 63.93 lb, was diagnosed with bone sarcoma and. Ifosfamide dosage: 3080 Mg Daily Iv. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MESNA (View Mesna Review and Mesna Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized and became disabled.